Aries Wealth Management Purchases Shares of 531 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Aries Wealth Management acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the first quarter, according to the company in its most recent filing with the SEC. The firm acquired 531 shares of the medical equipment provider's stock, valued at approximately $263,000.

Several other hedge funds have also added to or reduced their stakes in the business. Brighton Jones LLC increased its position in shares of Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock worth $1,916,000 after buying an additional 731 shares during the period. Union Bancaire Privee UBP SA bought a new stake in Intuitive Surgical during the fourth quarter valued at $6,509,000. Bank of Stockton grew its holdings in Intuitive Surgical by 13.5% during the 4th quarter. Bank of Stockton now owns 1,161 shares of the medical equipment provider's stock worth $606,000 after acquiring an additional 138 shares during the period. Blue Trust Inc. raised its position in shares of Intuitive Surgical by 19.7% in the 4th quarter. Blue Trust Inc. now owns 4,467 shares of the medical equipment provider's stock worth $2,332,000 after acquiring an additional 734 shares in the last quarter. Finally, Valeo Financial Advisors LLC raised its position in shares of Intuitive Surgical by 1.8% in the 4th quarter. Valeo Financial Advisors LLC now owns 4,193 shares of the medical equipment provider's stock worth $2,188,000 after acquiring an additional 74 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. Royal Bank of Canada lowered their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Barclays cut their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research report on Thursday, April 24th. Truist Financial decreased their target price on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research report on Wednesday, April 23rd. Robert W. Baird cut their price target on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Finally, Citigroup reaffirmed a "buy" rating and set a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $588.95.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG traded up $6.86 during trading on Monday, reaching $519.04. 1,513,773 shares of the stock traded hands, compared to its average volume of 1,675,177. The stock has a market capitalization of $186.03 billion, a P/E ratio of 80.97, a price-to-earnings-growth ratio of 5.85 and a beta of 1.67. Intuitive Surgical, Inc. has a 52-week low of $413.82 and a 52-week high of $616.00. The company has a 50-day moving average of $526.57 and a 200-day moving average of $538.46.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The company had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. During the same period in the prior year, the company posted $1.50 EPS. Analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Jami K. Nachtsheim sold 2,400 shares of the firm's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the transaction, the director now directly owns 6,371 shares of the company's stock, valued at $3,312,920. This trade represents a 27.36% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Robert Desantis sold 188 shares of the stock in a transaction on Monday, April 28th. The stock was sold at an average price of $515.91, for a total value of $96,991.08. Following the completion of the sale, the executive vice president now owns 5,224 shares in the company, valued at $2,695,113.84. This trade represents a 3.47% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 4,998 shares of company stock worth $2,611,577. 0.70% of the stock is owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.